- News- ID experts dole out practical advice to help with mask confusion- May 21, 2021- The CDC did not ‘’lift” the mask mandate, but rather supplied guidance for those who are fully vaccinated. 
- News- Care of post–acute COVID-19 patients requires multidisciplinary collaboration- May 21, 2021- Expert addresses pathophysiology, epidemiology, and management of patients with postacute COVID-19 syndrome. 
![1]() - News- Some things pediatric hospitalists do for no reason- May 20, 2021- Pediatric hospitalists should take note of some care management practices which are not supported by recent literature. 
![1]() - News- Hospital outcomes for children with MIS-C unaffected by initial presentation site- May 20, 2021- The length of hospital stay and rate of pediatric ICU admission were not significantly different between the emergency presentation and outpatient presentation groups. 
- News- Worse outcomes for patients with COPD and COVID-19- May 19, 2021- Worse outcomes include 14-day hospitalization, length of stay, ICU admission, 30-day mortality, and use of mechanical ventilation. 
- News- Atorvastatin: A potential treatment in COVID-19?- May 19, 2021- Atorvastatin was not associated with any significant differences in any of the individual components of the primary composite endpoint. 
![1]() - News- Procalcitonin-guided antibiotic stewardship for lower respiratory tract infection- May 18, 2021- For hospitalists, the most clinically useful role for PCT testing is to guide the duration of antibiotic therapy. 
![1]() - News- COVID-19 in children: Weekly cases drop to 6-month low- May 18, 2021- No increase seen in children’s share of weekly and cumulative cases. 
- News- Dr. Fauci: Extraordinary challenges, scientific triumphs with COVID-19- May 18, 2021- “The speed and efficiency with which these highly efficacious vaccines were developed, and their potential for saving millions of lives, are due to an extraordinary multidisciplinary effort.” 
![1]() - News- FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD- May 18, 2021- A prespecified, exploratory analysis from the FIDELIO-DKD trial showed that the nonsteroidal MRA finerenone significantly cut new-onset AFib. 




